Skip to main content

Andrew Paul Landstrom

Associate Professor of Pediatrics
Pediatrics, Cardiology
Duke University Medical Center, Box 2652, Durham, NC 27710
Duke University Medical Center, Box 2652, Durham, NC 27710

Selected Grants


Determining the genetic and social determinants of heart failure and mortality in patients with congenital heart disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028

Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2028

The role of the sodium potassium ATPase type alpha-3 subunit in sudden cardiac arrest

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Medical Scientist Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2027

Implantable Cardioverter Defibrillator Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia

ResearchPrincipal Investigator · Awarded by University of British Columbia · 2021 - 2027

Determining the genetic and social determinants of heart failure and mortality in patients with congenital heart disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028

Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2028

The role of the sodium potassium ATPase type alpha-3 subunit in sudden cardiac arrest

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Medical Scientist Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2027

Implantable Cardioverter Defibrillator Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia

ResearchPrincipal Investigator · Awarded by University of British Columbia · 2021 - 2027

Improving Diagnosis and Treatment in CPVT

ResearchPrincipal Investigator · Awarded by University of British Columbia · 2021 - 2027

Physical activity in Catecholaminergic Polymorphic Ventricular Tachycardia

ResearchPrincipal Investigator · Awarded by University of British Columbia · 2021 - 2027

Training Program in Developmental and Stem Cell Biology

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Engineered BacNav and BacCav for Improved Excitability and Contraction

ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2026

Determining the role of ATP1A3-D801N in short QT mediated sudden cardiac arrest

ResearchMentor · Awarded by Pediatric & Congenital Electrophysiology Society · 2023 - 2025

Genetic and Genomics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025

Evaluating Wnt-Modulators as a Therapy for Treatment of Arrhythmic Cardiomyopathy In Vivo

ResearchPrincipal Investigator · Awarded by Hartwell Foundation · 2022 - 2025

DDF Paragon Award Agreement

ResearchPrincipal Investigator · Awarded by Doris Duke Charitable Foundation, Inc. · 2024 - 2024

Leveraging DSP-positive iPSC-derived cardiac myocytes to test new therapies for arrhythmic cardiomyopathy

ResearchPrincipal Investigator · Awarded by John Taylor Babbitt Foundation · 2023 - 2024

The North Carolina Congenital Heart Disease Surveillance Network

Public ServiceCollaborating Investigator · Awarded by Centers for Disease Control and Prevention · 2019 - 2024

Unified Program for Therapeutics in Children

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2019 - 2024

The role of PRDM16 in Cardiac Development and Cardiomyopathy

ResearchPrincipal Investigator · Awarded by University of Utah · 2023 - 2024

Duke CTSA (TL1) Year 5

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024

Targeting Wnt-signaling to prevent sudden death in pediatric arrhythmic cardiomyopathyTBD

ResearchPrincipal Investigator · Awarded by Doris Duke Charitable Foundation, Inc. · 2020 - 2024

Bridging the Gap to Enhance Clinical Research Program (BIGGER)

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2016 - 2023

Establishing Wnt signaling-mediated pro-arrhythmic cardiac remodeling

FellowshipPrincipal Investigator · Awarded by American Heart Association · 2021 - 2023

Establishing the role of DSP in inflammation-induced arrhythmic cardiomyopathy

ResearchPrincipal Investigator · Awarded by John Taylor Babbitt Foundation · 2022 - 2023

Cord blood-based biomarker discovery for sudden infant death syndrome risk

ResearchPrincipal Investigator · Awarded by American SIDS Institute · 2020 - 2022

Medical Scientist Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1997 - 2022

The Role of Junctophilin Type 2 in Cardiac Node Automaticity

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2022

Determining the role of PRDM16 in rapidly progressive pediatric cardiomyopathy

ResearchPrincipal Investigator · Awarded by American Academy of Pediatrics · 2019 - 2021

Fellowships, Gifts, and Supported Research


The role of junctophilin-2 in the development of youthful sinus and atrioventricular nodal disease · 2016 - 2017 Pediatric and Congenital Electrophysiology Society
The role of RyR2-Asn4643del in CPVT with emotionally-triggered sudden death · 2015 - 2017 National Institutes of Health
In vivo evaluation of novel anti-arrhythmic compounds to terminate potentially fatal tachyarrhythmia · 2018 - 2018 Mike Hogg Fund